Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Xtant Medical Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $27.9 million, net income $4.3 million, or $0.03 per share, EPS $0.03 per share. Guidance raised.
- Period
- first quarter ended March 31, 2024
- Revenue
- $27.9 million
- Net income
- $4.3 million, or $0.03 per share
- EPS
- $0.03 per share
- Guidance
- raised
- Result
- reported results
Exact text from the filing
treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights ● Revenue of $27.9 million, up 55%, compared to the prior year quarter ● Gross margin of 62.1%, up 340 basis points, compared to the prior year quarter ● Net loss of $4.4 million compared to $2.1 million
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
Xtant Medical Holdings, Inc. reported full year 2024 results: revenue $116 million to $120 million. Guidance raised.
- Period
- full year 2024
- Revenue
- $116 million to $120 million
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
Xtant Medical raises its expectation for full year 2024 revenue to $116 million to $120 million, up from the Company’s prior guidance of $112 million to $116 million.
View on SEC.gov